Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)Gergő A Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltan Kiss
24 January 2024
Diabetes and chronic kidney disease in Chinese adults: a population-based cohort studyXue Wang, Lu Chen, Kexiang Shi, Jun Lv, Dianjianyi Sun, Pei Pei, Ling Yang, Yiping Chen, Huaidong Du, Jiaqiu Liu, Xiaoming Yang, Maxim Barnard, Junshi Chen, Zhengming Chen, Liming LiSee the full list of authors
24 January 2024
Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction modelsHuan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Tetsuya Mizoue
8 January 2024
High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practiceKatrina Tibballs, Anne Karen Jenum, Lars Kirkebøen, Tore Julsrud Berg, Tor Claudi, John Graham Cooper, Kjersti Nøkleby, Sverre Sandberg, Jørund Straand, Esben Selmer Buhl
2 January 2024
Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitisAnastasia-Stefania Alexopoulos, Alice Parish, Maren Olsen, Bryan C Batch, Cynthia Moylan, Matthew J Crowley
29 November 2023
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort studyRicheek Pradhan, Oriana H Y Yu, Robert W Platt, Laurent Azoulay
10 November 2023
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera-Barrios, Christopher G Owen, John Anderson, Alasdair N Warwick, Ryan Chambers, Louis Bolter, Yue Wu, Roshan Welikala, Jiri Fajtl, Sarah A Barman, Paolo Remagnino, Emily Y Chew, Frederick L Ferris, Aroon D Hingorani, Reecha SofatSee the full list of authors
10 November 2023
Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USALorissa Pagán, Wenya Yang, Hui Shao, Yu Wang, Ping Zhang
1 November 2023
Can earlier biomarker measurements explain a treatment effect on diabetes incidence? A robust comparison of five surrogate markersLayla Parast, Lu Tian, Tianxi Cai, Latha P Palaniappan
31 October 2023
Influence of neighborhood-level socioeconomic deprivation and individual socioeconomic position on risk of developing type 2 diabetes in older men: a longitudinal analysis in the British Regional Heart Study cohortKathryn J Bush, A Olia Papacosta, Lucy T Lennon, Judith Rankin, Peter H Whincup, S Goya Wannamethee, Sheena E Ramsay
31 October 2023